Osaka, Japan

Koichiro Shibamori

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koichiro Shibamori. Retrieved from https://idiyas.com/inventor/koichiro-shibamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koichiro Shibamori: Innovator in Medicament-Containing Particles

Introduction

Koichiro Shibamori is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicament-containing particles that improve the administration of unpleasant-tasting medications.

Latest Patents

Shibamori holds a patent for a medicament-containing particle and a solid preparation that includes this particle. The invention addresses the challenge of alleviating the unpleasant taste of certain medications. By mixing and granulating specific ingredients, including the medicament, methylcellulose, and mannitol, the formulation not only masks the unpleasant taste but also enhances the dissolvability of the medication in the gastrointestinal tract. He has 1 patent to his name.

Career Highlights

Shibamori is associated with Dainippon Sumitomo Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical formulations. His work focuses on improving patient compliance through innovative solutions that enhance the palatability of medications.

Collaborations

Some of his notable coworkers include Keiichi Fujiwara and Kiyomi Sogo, who have collaborated with him on various projects within the pharmaceutical industry.

Conclusion

Koichiro Shibamori's innovative work in medicament-containing particles exemplifies the importance of addressing patient needs in medication administration. His contributions continue to impact the pharmaceutical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…